Failures to Replicate: What Recent Negative Phase 3 Trials Have Taught Us about Amyotrophic Lateral Sclerosis Clinical Research

J.M.S. has received research funding and personal compensation for consulting from Cytokinetics, Amylyx Pharmaceuticals, MT Pharma, and Biogen. M.E.C. has received research funding from Amylyx Pharmaceuticals and Cytokinetics, and personal compensation from Cytokinetics, Amylyx Pharmaceuticals, MT Pharma, and Biogen.